The DETOUR2 Study addressed patients with complex anatomy, including long lesions, chronic total occlusions, and in-stent restenosis. #PTAB #DETOURSystem #SFA #PeripheralArteryDisease ISI:

Experience the AFX2 difference: Real world data supports the performance of the AFX2 system. Explore these results compared to proximal fixation. #AFX2 #LEOPARDRCT #AAA ISI:

With the AFX2 System, the bifurcated unibody design preserves the native bifurcation and enables future reinterventions. #AFX2 #LEOPARDRCT #AAA ISI:

Watch PTAB patients share their treatment journey and success stories and share with your patients today! #PADawareness #peripheralarterydisease #PAD ISI:

Our website has a comprehensive collection of resources for our ALTO and AFX2 endovascular systems. Come see what's new... #EVAR #AAA #ALTO #AFX2

Most patients with extensive disease of the SFA fall into one of five general categories, and they may benefit from PTAB with the DETOUR System. Click here to read more. #PTAB #DETOURSystem #SFA #PeripheralArteryDisease ISI:

Congratulations to Dr. Tak Kwan, Dr. Arsalan Rehmani & the team from Lenox Hill Hospital in New York, NY on their first PTAB case with the DETOUR System. Learn more about the DETOUR System here #PAD #PTAB #DETOURSystem

Curious about the ALTO Stent Graft? Dr. Nicolas Mouawad highlights the clinical utility of the ALTO graft. In this short testimonial he covers patient demographics, pre-case planning, intra and post-op results. #AAA #vascsurg ISI:

Listen to the CME/CNE/CCI-Accredited webcast for PTAB therapy. The goal of this program is to understand PTAB, where it fits into the PAD treatment, and create an algorithm for the ideal candidate. #PTAB #PAD #HMP ISI:

We're thrilled to announce that our recent PTAB with the DETOUR System New Hire Workshop was a huge success! New hires took a deep dive into the DETOUR System, mastering the technology that’s revolutionizing the #PAD space. Join us in welcoming them to the #PTAB family!

Did You Miss the DETOUR™ System 3-year Data Presentations at VIVA24 and VEITH24? Click here to download a clinical summary with the long-term results of the DETOUR System: #PTAB #Latebreakingdata #VIVA24 #VEITH24 #PAD ISI:

Patient presented with long diffuse SFA disease and was not a suitable candidate for open bypass surgery. Congratulations to Dr. Eric Shang from Lehigh Valley Hospital–Cedar Crest in Allentown, PA on his first PTAB case with the DETOUR System.

Did you know that in the DETOUR2 trial, patients undergoing PTAB with the DETOUR System consistently reported improvements in their Rutherford Classification. #PTAB #DETOURSystem #SFA #PeripheralArteryDisease ISI:

ALTO helps you treat more AAA patients and provides on-label treatment of the broadest range of patients. #AAA #vascsurg #EVAR ISI:

80-year-old female patient presented with 37 cm long-segment SFA. Congratulations to Dr. Carleen Cho from Millcreek Community Hospital in Erie, PA on her first PTAB case with the DETOUR System. Learn more about the DETOUR System here #PAD #PTAB

Click to hear from Dr. Robert Beaulieu, Vascular Surgeon at the University of Michigan, as he discusses an ALTO Case. #AAA #vascsurg #EVAR ISI:

Endologix is pleased to announce the appointment of Dr. John Liddicoat as Chief Executive Officer! Read the press release here:

How do other physicians incorporate DETOUR into their treatment algorithm? Read the Endovascular Today supplement from various DETOUR System experts and how it has benefitted their patients. #SFA #ComplexPAD ISI:

The ALTO Stent Graft is Anatomically Adaptive and Uniquely Powerful. Explore a Pre and Post #EVAR case example here: #AAA #vascsurg #EVAR ISI:

Click here to watch the new HMP CME Program titled: "Percutaneous Transmural Arterial Bypass Therapy- New Option for those with no option?" #PTAB #DETOURSystem #SFA #PeripheralArteryDisease